Efficacy of Tixagevimab-Cilgavimab in Preventing Sars-Cov-2 in Hematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy Recipients

Detalles Bibliográficos
Autores principales: McGann, Mary, Davis, James, Roubal, Kiera, Granger, Katelynn, Smith, Deidra, Gaffney, Kelly, Thurlapati, Aswani, Herbst, Amanda, Hendrickson, Lindsey, Hess, Brian T, Hashmi, Hamza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2023
Materias:
Poster Session: Infectious Diseases and Cytotoxic T Lymphocytes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899532/
http://dx.doi.org/10.1016/S2666-6367(23)00512-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899532/
http://dx.doi.org/10.1016/S2666-6367(23)00512-2

Ejemplares similares